Landscapes / Targets
SSTR
14 drugs act on SSTR, in 19 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs14
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Approved | Aug 2027Phase 3 trial completes | |||
| Next date | Aug 2027 · Phase 3 trial completes | ||||
| Also tested for | Carcinoid Syndrome, Carcinoid and 7 more | ||||
| Open drug page | |||||
— |
Approved | 7 Mar 2028Phase 1/2 trial completes | |||
| Next date | 7 Mar 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Glioblastoma, Extensive Stage Small Cell Lung Cancer | ||||
| Open drug page | |||||
— |
Approved | 7 Mar 2028Phase 1/2 trial completes | |||
| Next date | 7 Mar 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Gastroenteropancreatic Neuroendocrine Tumors, Pheochromocytoma and 3 more | ||||
| Open drug page | |||||
— |
Phase 3 | 24 Nov 2026soonPhase 3 trial completes | |||
| Next date | 24 Nov 2026 · Phase 3 trial completes | ||||
| Also tested for | NETS Ga68 Lu177 | ||||
| Open drug page | |||||
— |
Phase 3 | Dec 2026Phase 3 trial completes | |||
| Next date | Dec 2026 · Phase 3 trial completes | ||||
| Also tested for | GEP-NET, Gastroenteropancreatic Neuroendocrine Tumor and 16 more | ||||
| Open drug page | |||||
— |
Phase 2/3 | 1 Jun 2027Phase 2/3 trial completes | |||
| Next date | 1 Jun 2027 · Phase 2/3 trial completes | ||||
| Also tested for | Advanced Neuroendocrine Neoplasm | ||||
| Open drug page | |||||
— |
Phase 3 | Jun 2027Phase 3 trial completes | |||
| Next date | Jun 2027 · Phase 3 trial completes | ||||
| Also tested for | Neuroendocrine Tumors, Somatostatin Receptor Positive and 7 more | ||||
| Open drug page | |||||
— |
Phase 2 | Dec 2026Phase 2 trial completes | |||
| Next date | Dec 2026 · Phase 2 trial completes | ||||
| Also tested for | Type 1 Diabetes Mellitus With Hypoglycemia | ||||
| Open drug page | |||||
Mazisotinenot checked |
— |
Eli Lilly · Public LLY |
Phase 2 | Apr 2027Phase 2 trial completes | |
| Next date | Apr 2027 · Phase 2 trial completes | ||||
| Also tested for | Osteoarthritis, Knee, Diabetic Neuropathic Pain and 1 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | Aug 2027Phase 1/2 trial completes | |||
| Next date | Aug 2027 · Phase 1/2 trial completes | ||||
| Also tested for | SST2-positive Neuroendocrine Neoplasms, Neuroendocrine Tumors and 1 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | 26 Nov 2029Phase 1/2 trial completes | |||
| Next date | 26 Nov 2029 · Phase 1/2 trial completes | ||||
| Also tested for | Neuroendocrine Tumors Unresectable, Neuroendocrine Tumor Metastatic and 5 more | ||||
| Open drug page | |||||
— |
Phase 2 | — | |||
| Also tested for | Neuroendocrine Tumors | ||||
| Open drug page | |||||
— |
Phase 1 | Feb 2027Phase 1 trial completes | |||
| Next date | Feb 2027 · Phase 1 trial completes | ||||
| Also tested for | GEP-NET, Gastroenteropancreatic Neuroendocrine Tumor and 7 more | ||||
| Open drug page | |||||
— |
Phase 1 | Apr 2027Phase 1 trial completes | |||
| Next date | Apr 2027 · Phase 1 trial completes | ||||
| Also tested for | Acromegaly | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 13 of 14 drugs. The other 1 is marked “not checked” in the list. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026